跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
舒美奋 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Buprenorphine Hydrochloride Sublingual Tablets
Approved
化学药品
Buprenorphine Hydrochloride Sublingual Tablets
丽珠集团丽珠制药厂
🇨🇳 National Medical Products Administration
Approval Date
Apr 9, 2020
Approval ID
7LeafnshTxz
Company
丽珠集团丽珠制药厂
Type
化学药品
Approval Details
Approval Id
7LeafnshTxz
Approval Number
国药准字H10970343
Generic Name
盐酸丁丙诺啡舌下片
Generic Name En
Buprenorphine Hydrochloride Sublingual Tablets
Trade Name
舒美奋
Drug Type
化学药品
Dosage Form
片剂(舌下片)
Strength
0.2mg
Reg Date
2020-04-09
Company Name
丽珠集团丽珠制药厂
Production Company Name
丽珠集团丽珠制药厂
Production Company Address
珠海市金湾区创业北路38号
Company Detail Path
/organization/li-zhu-ji-tuan-li-zhu-zhi-yao-han
Production Company Detail Path
/organization/li-zhu-ji-tuan-li-zhu-zhi-yao-han
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 9, 2020
Approval ID
7LeafnshTxz
Type
化学药品
Back to NMPA Approvals